With over 100 labs scrambling to develop COVID-19 vaccination, pharma executives hopeful for roll out before 2021, but cite ‘daunting’ challenges in producing billions of doses
With over 100 labs scrambling to develop COVID-19 vaccination, pharma executives hopeful for roll out before 2021, but cite ‘daunting’ challenges in producing billions of doses